During the past decade, Piedmont Research Partners conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Research Partners" #1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator, "LGC Limited" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Research Partners" are "Overactive Bladder" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "COPD" (1 trials), "Chronic Kidney Disease (CKD)" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Piedmont Research Partners" in a lesser frequency.

Most popular intervention types in "Piedmont Research Partners" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Tolterodine Tartrate ER" (2 trials), "Ensifentrine" (1 trials), "Ensifentrine (formerly RPL554) 0.375 mg twice daily plus placebo, in addition to tiotropium" (1 trials) and "Ensifentrine (formerly RPL554) 0.75 mg twice daily plus placebo, in addition to tiotropium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Research Partners" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Research Partners". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Piedmont Research Partners, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Research Partners, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".